CDCP2
CUB domain-containing protein 2
Also known as: CDCP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VXM1
- Gene
- CDCP2
- Ensembl
- ENSG00000157211
- Chromosome
- 1
- Canonical length
- 540 aa
- Protein class
- Predicted membrane proteins, Predicted secreted proteins
- Secretome location
- Secreted - unknown location
OverviewNCBI Gene
Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
540 residues, UniProt reviewed canonical sequence.
>Q5VXM1|CDCP2
1 MLAEWGACLL LAVALLGPGL QAQAMEGVKC GGVLSAPSGN FSSPNFPRLY PYNTECSWLI
61 VVAEGSSVLL TFHAFDLEYH DTCSFDFLEI YNGASPDKGN LLGRFCGKVP PPPFTSSWHV
121 MSVIFHSDKH VASHGFSAGY QKDVCGGVLT GLSGVLTSPE YPNNYPNSME CHWVIRAAGP
181 AHVKLVFVDF QVEGNEECTY DYVAVLGGPG PTRGHHYCGS TRPPTLVSLG HELQVVFKSD
241 FNIGGRGFKA YYFSGECQEV YMAMRGNFSS PQYPSSYPNN IRCHWTIRLP PGYQVKVFFL
301 DLDLEEPNSL TKTCDFDHLA AFDGASEEAP LLGNWCGHHL PPPVTSSHNQ LLLLLHTDRS
361 TTRRGFSVAY IGVVPMNVSC SRTDFQILIS TQALAPLERT KVYLGSRSCA AQEVGGNLRI
421 QARFDTCGTE SQRRNNTSVI VSVLYIDFSA AGREDIHEYE VRCEPRRKEA SVHLLSGSHW
481 LGPYAATAEH LQEAPPMDEA EALEGPVSMV AQDTSDIVFL GLCILAGILM VIAIVVLMLLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDCP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 0.1 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 0.1 nTPM
- breast: 0.1 nTPM
- cerebral cortex: 0.1 nTPM
- cervix: 0.1 nTPM
- choroid plexus: 0.1 nTPM
- spleen: 0.1 nTPM
Single-cell type
- astrocytes: 0.1 nCPM
- brain excitatory neurons: 0.1 nCPM
- brain inhibitory neurons: 0.1 nCPM
- oligodendrocytes: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.7 nTPM
- amygdala: 0.5 nTPM
- basal ganglia: 0.4 nTPM
- hippocampal formation: 0.4 nTPM
- white matter: 0.3 nTPM
- hypothalamus: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.79
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.02
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDCP2 as an antibody target. Whether an autoantibody or antibody against CDCP2 could matter depends on whether native CDCP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDCP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDCP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...